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Abstract
OBJECTIVE: To investigate the effects of transcuta-
neous electrical nerve stimulation (TENS) through
acupoints on the intraocular pressure (IOP) in pa-
tients with glaucoma.
METHODS: A single-blinded, randomized experi-
mental design study was conducted. Patients from
the North of Taipei Ophthalmology outpatient de-
partment diagnosed with intraocular hypertension
were selected and were further enrolled if they met
the research subject criteria. The patients who met
all criteria, and who met no exclusion criteria be-
came the participants. Participants were randomly
assigned into the treated group, wherein the TENS
electrodes (Qing Ming Medical Device Co., Ltd.,
New Taipei City, China) were applied with direct cur-
rent (DC) on the acupoints Pucan (BL 61) and Shen-
mai (BL 62) for 20 min. The control group received
no TENS electrode treatments. Measurements of
IOP were taken four times using a pneumotonome-
ter (Clinico Co., Ltd., New Taipei City, China), before,
immediately after, 30 min after, and 60 min after
TENS electrode treatments.
RESULTS: Eighty-two participants completed the
experiment. IOP decreased more in the group treat-
ed with DC (P < 0.01) than in the control group. The
IOPs were not affected by the age of the patients
and their usage of medications.
CONCLUSION: TENS of acupoints of Pucan (BL 61)
and Shenmai (BL 62) could significantly reduce the
IOP in patients with glaucoma.
© 2016 JTCM.
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INTRODUCTION
Glaucoma is an eye disease caused by increased fluid
pressure in the eye. If left untreated, patients may lose
the field of vision and eventually become blind due to
optic neuropathy. According to the World Health Or-
ganization, glaucoma is the second-ranked eye disease
in the world that causes blindness. Moreover, about
five million people have become blind due to glauco-
ma. In Taiwan, glaucoma is also a serious disease. The
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Taiwan Bureau of National Health Insurance gathered
data in 2010 and estimated that about 100 000 Tai-
wanese suffered from glaucoma.1
The European Glaucoma Society defines glaucoma as a
combination of diseases caused by multiple mecha-
nisms. Progressive optic neuropathy is often observed,
and it is accompanied by visual field defects, which can
cause the patient to become visually compromised and
have a poor quality of life.2
Normally, the aqueous humor is secreted into the pos-
terior chamber by the ciliary body. It flows through the
narrow cleft between the front of the lens and the back
of the iris and exits through the pupil into the anterior
chamber. The aqueous humor then exits the eye
through the trabecular meshwork and into the Sch-
lemm's canal, and flows into the episcleral veins and
enters the blood circulation system of the body.3 If a
blockage occurs in any part of the pathway, the aque-
ous humor will cause an increase in intraocular pres-
sure (IOP). Once IOP exceeds the optimal physiologi-
cal range, the pressure increase will result in glaucoma.
Thus, it is very important to maintain normal IOP in
the eye.4
Many risk factors are associated with glaucoma, but
most remain unknown. Recent evidence-based medi-
cine (EBM) studies indicate that lowering IOP is an ef-
fective method to control the progression of glaucoma.
Through medication and laser and surgical operations,
most patients are able to maintain adequate control of
IOP, but sometimes unfavorable results are observed.
Some patients show increased IOP, resulting in the pro-
gression of visual defects. Traditional Chinese Medi-
cine, however, is an alternative treatment for such pa-
tients, and could provide an improved quality of life.5
In Traditional Chinese Medicine, the theories of merid-
ian and collateral are important; these are pathways of
the Qi and blood, and of the entire body, including
Zang-Fu organs and the body surface. The meridian
runs vertically, bilaterally, and symmetrically in the
body, while the collateral branches off from channels,
and connects to every part of the body.6 In addition,
acupoints are located on the surface of the body, with
most located along meridians. They are not only the
stimulating points usually used for applying acupunc-
ture treatment, but they are also the reaction points of
the diseases on the surface of the body.7 Acupuncturists
apply treatment by considering the Zang-Fu organs, or-
ifices, skins, tendons, bones, and all the other compo-
nents of the body as a whole.8
The bladder meridian of the foot, Taiyang (BL), origi-
nates from the inner canthus of the eye, Jingming (BL
1), then extends up through the eyebrows, Cuanzhu
(BL 2), and passes through the forehead. It terminates
at the posterior side of the tip of the little toe. The
pathway of this channel matches the drainage route of
the aqueous humor.9 In addition, the Yan heel channel
is one of the eight additional meridians that extend
along the outside of the lower limbs. The channels
nourish the eyes and adjust eyelid movements.10 The
acupoint, Shenmai (BL 62), belongs to the taiyang
bladder channel of the foot, and it is a confluent point
marking the starting pathway of the yan heel channel.
According to the theory of Traditional Chinese Medi-
cine, stimulation of the acupoint, Pucan (BL 61), locat-
ed posteriorly and inferiorly to the lateral malleolus
and in the depression on the lateral calcaneus, and
Shenmai (BL 62), located in a depression directly be-
low the lateral malleolus, greatly increases aqueous hu-
mor outflow through the urinary system.11 In Tradition-
al Chinese Medicine, this involves treatment of upper
body diseases through the lower body organs.12
Traditional Chinese Medicine proposes that the imbal-
ance of the ying and yang is what causes a disease. Di-
rect current (DC) applied to acupoints may have
two-way effects, either enhancing or weakening the
body strength based on how the ying and yang are im-
balanced. Once the Ying and the Yang are rebalanced,
the treatment is successful.13 Normally, the duration of
transcutaneous electrical nerve stimulation (TENS) of
acupoints with DC is between 15 and 20 min.14 Cur-
rently, there are very few clinical studies on the treat-
ment of glaucoma using acupoint techniques. The pres-
ent study investigated whether the TENS of acupoints
of Pucan (BL 61) and Shenmai (BL 62) with DC
could reduce the IOP.
MATERIALS ANDMETHODS
The research was approved by the institutional commit-
tee (TCHIRB-1030103-E) and conformed to the te-
nets of the Declaration of Helsinki. It was a sin-
gle-blinded, randomized controlled clinical study. The
participants were patients at the ophthalmology outpa-
tient department from Taipei City Hospital in Taiwan.
Inclusion criteria were: age of 20 years or above; intra-
ocular pressure above 22 mm Hg; either one or both
eyes with glaucoma or intraocular hypertension; not
pregnant; no cancer diagnosed; clear consciousness
(mentally normal and without a mental illness); mini-
mum education level of junior high school; capable of
communication (speaking either Chinese or Taiwan-
ese); agreed to participate in the experiment and signed
the informed consent with guarantee of full participa-
tion in the experiment.
Exclusion criteria were: laser surgery for either glauco-
ma or myopia; inflammation of eyes; intraocular hyper-
tension caused by cataract or other eye diseases; two or
more injected and/or systemic medications that low-
ered the IOP; at the end stage of glaucoma (severe op-
tic neuropathy); unclear consciousness; uncooperative
during the experiment; unwilling to sign the informed
consent; unable to participate throughout the entire ex-
perimental period.
Eighty-two participants were included and were ran-
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domly assigned into two groups. Participants were
blinded from knowing their group identity.
The IOPs of all participants were measured. The exper-
imental group was treated with DC on acupoints of Pu-
can (BL 61) and Shenmai (BL 62) through TENS for
20 min while the control group was subjected to
TENS electrodes on the same acupoints, but without
DC. Another IOP measurement was immediately tak-
en. After 30 min, a third IOP measurement was taken,
and IOP was also measured after 60 min (Figure 1).
Statistical analysis
Statistical analyses were conducted on the basic person-
al information of all participants including gender, age,
height, weight, body mass index (BMI), symptoms,
and medication usage. Categorical data are shown in
numbers and percentages, while continuous variables
are given as mean ± standard deviation ( xˉ ± s). Inde-
pendent sample t-tests were used to examine the dis-
crepancy of IOPs between the right and left eyes of the
two groups. Pearson product-moment correlation anal-
yses and independent sample t-tests were used to dem-
onstrate the moderating effects of age and medication
usage. Ages and medication usage were set as indepen-
dent variables.
RESULTS
Demographics
There were 47 (57.3%) female and 35 (42.7%) male
participants. The average age, height, and weight were
55.06 years of age, 161.75 cm, and 59.81 kg, respec-
tively. The average BMI was 22.83. Fifty participants
(61.0%) were in the normal range of BMI, and 21 par-
ticipants (25.6%) were considered as overweight by the
BMI standards.
There were 55 participants (67.1%) who did not take
medications, and 75 participants (91.5% ) had no
symptoms. In terms of homogeneity comparisons,
there was no significant difference between gender, age,
height, weight, BMI, medication usage, and symptoms
in independent sample t-tests and chi-square tests (P >
0.05, Table 1). The IOP discrepancy between the right
and left eyes did not meet the significance level (P >
0.05) (Table 2) .
IOP measurements
The IOPs of the right eyes of the experimental group
dropped by 3.36 mm Hg, and in the control group the
IOPs of the right eyes dropped by 0.55 mm Hg when
measured after TENS. The measurements taken 30 min
Figure 1 Procedures of this study
IOP: intraocular pressure; DC: direct current.
Patients with high
IOP
The criteria were set for
subject selection
The research was explained
and subjects were selected
(n = 82)
The informed consent
was obtained (n = 82) Control group (n = 42)Experimental
group (n = 40) First IOP measurement
was recorded (n = 82) IOP was measured using a
pneumotonometer (n = 82)
DC was applied to TENS
electrodes for 20 min (n = 40) No DC was applied to
TENS electrodes (n = 42)
IOP was measured immediately (n = 82)
IOP was measured using a
pneumotonometer (n = 82)
IOP was measured after 30 min (n = 82)
IOP was measured after 60 min (n = 82)
Measurements were recorded (n = 82)
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after the TENS showed that the experimental group
had right eye IOP decreases of 3.40 mm Hg, while the
control group IOPs had risen by 0.47 mm Hg. More-
over, at 60 min after TENS, the experimental group
right eye IOPs had dropped by 3.45 mm Hg, while the
control group right eye IOPs had risen by 0.57 mm
Hg (Table 3) .
Immediately after TENS, the left eye IOPs dropped by
3.46 mm Hg for the experimental group, and by
0.88 mm Hg for the control group. The measurements
taken 30 min after TENS showed that the left eye
IOPs had dropped by 3.61 mm Hg for the experimen-
tal group and by 0.05 mm Hg for the control group.
After 60 min, the experimental group left eye IOPs
Item
Gender [n (%)]
Age (years)
Height (cm)
Weight (kg)
BMI value
BMI groups [n (%)]
One medication that can
lower IOP was taken [n (%)]
Symptom [n (%)]
Variability
Male
Female
Underweight
Normal
Overweight
Obese
Yes
No
Yes
No
Total (n = 82)
35 (42.7)
47 (57.3)
55.1±19.4
161.8±7.2
59.8±9.1
22.8±2.9
5 (6.1)
50 (61.0)
21 (25.6)
6 (7.3)
27 (32.9)
55 (67.1)
7 (8.5)
75 (91.5)
Experimental (n = 40)
13 (32.5)
27 (67.5)
54.0±19.4
160.6±7.4
58.6±9.7
22.6±3.1
3 (7.5)
24 (60.0)
11 (27.5)
2 (5.0)
14 (35.0)
26 (65.0)
5 (12.5)
35 (87.5)
Control (n = 42)
22 (52.4)
20 (47.6)
56.1±20.0
162.8±6.8
61.0±8.5
23.0±2.8
2 (4.8)
26 (61.9)
10 (23.8)
4 (9.5)
13 (31.0)
29 (69.0)
2 (4.8)
40 (95.2)
t / χ2 value
3.310
-
－0.492
－1.394
－1.210
－0.564
0.946
-
-
-
0.152
-
1.571
-
P value
0.069
-
0.624
0.167
0.230
0.574
0.814
-
-
-
0.697
-
0.210
-
Notes: the experimental group was treated with DC on acupoints of Pucan (BL 61) and Shenmai (BL 62) through TENS for 20 min while
the control group was subjected to TENS electrodes on the same acupoints, but without DC. TENS: transcutaneous electrical nerve stimu-
lation; DC: direct current; IOP: intraocular pressure.
Table 1 Basic information of subjects in the experimental group and control group ( xˉ ± s)
Pretest intraocular pressure
Right eye
Left eye
Control (n = 42)
n
30
18
Average
27.57
25.33
Deviation
7.34
2.06
Experimental (n = 40)
n
30
23
Average
25.96
25.89
Deviation
4.59
4.03
t value
1.023
－0.570
P value
0.311
0.573
Notes: the experimental group was treated with DC on acupoints of Pucan (BL 61) and Shenmai (BL 62) through TENS for 20 min while
the control group was subjected to TENS electrodes on the same acupoints, but without DC. TENS: transcutaneous electrical nerve stimu-
lation; DC: direct current; IOP: intraocular pressure.
Table 2 Analytical determination of IOPs in different groups
Effect after stimulation of right eye
Instant effect
Effect after 30 min
Effect after 60 min
Experimental (n = 40)
People
30
30
30
Average
－3.36
－3.40
－3.45
Deviation
2.59
1.58
1.51
Control (n = 42)
People
30
30
29
Average
－0.55
0.47
0.57
Deviation
1.72
1.98
1.84
t value
－4.952
－8.339
－9.171
P value
< 0.001
< 0.001
< 0.001
Notes: the experimental group was treated with DC on acupoints of Pucan (BL 61) and Shenmai (BL 62) through TENS for 20 min while
the control group was subjected to TENS electrodes on the same acupoints, but without DC. TENS: transcutaneous electrical nerve stimu-
lation; DC: direct current.
Table 3 Analytical determination of the changes of right eye intraocular pressures in different groups
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dropped by 3.61 mm Hg, and for the control group,
there were no left eye IOP changes when compared
with the measurements taken before the TENS elec-
trode was applied (Table 4) .
Age and the three IOPs, measured after the TENS elec-
trodes were applied for the experimental group,
showed no correlation (P > 0.05, Table 5).
The usage of different medications in the experimental
group showed no correlation (P > 0.05) with the IOPs
determined after the TENS electrodes were applied
(Table 6).
DISCUSSION
Glaucoma is an optic nerve disease, and the main cause
is elevated IOP, which eventually leads to the compres-
sion of the optic nerves, damage to the vision field, and
pathological effects on the optic nerves.15 These pathol-
ogies significantly impair vision functions. Glaucoma
is one of the major causes of blindness or loss of vision
worldwide.16 Glaucoma could increase and this would
critically impact public health. The TENS of acupoints
is a self-operative and a noninvasive treatment. This
study demonstrates that TENS of acupoints with DC
reduces IOP and improves glaucoma. Therefore,
TENS of acupoints with DC can be an alternative to
the management of IOP and may reduce the occur-
rence of blindness in glaucoma patients. In conclusion,
this study demonstrated a significant effect of TENS for
reducing the IOPs of patients suffering fromglaucoma.
Notes: the experimental group was treated with DC on acupoints of Pucan (BL 61) and Shenmai (BL 62) through TENS for 20 min while
the control group was subjected to TENS electrodes on the same acupoints, but without DC. TENS: transcutaneous electrical nerve stimu-
lation; DC: direct current.
Effect after stimulation of left eye
Instant effect
Effect after 30 min
Effect after 60 min
Experimental (n = 40)
n
17
18
18
Average
－3.46
－3.61
－3.61
Deviation
1.13
1.67
1.95
Control (n = 42)
n
23
22
22
Average
－0.88
－0.05
0.00
Deviation
2.23
1.90
1.98
t value
－4.799
－6.208
－5.773
P value
< 0.001
< 0.001
< 0.001
Table 4 Analytical determination of the changes of left eye intraocular pressures in different groups
Item
Right eye
Left eye
Effect after stimulation
Instant effect
Effect after 30 min
Effect after 60 min
Instant effect
Effect after 30 min
Effect after 60 min
One medication that can lower IOP was used
Yes (n = 14)
n
11
11
11
6
6
6
Average
－3.82
－3.53
－3.64
－2.87
－3.15
－2.70
Deviation
2.51
2.08
1.93
1.12
1.54
1.21
No (n = 26)
n
19
19
19
11
12
12
Average
－3.10
－3.32
－3.34
－3.79
－3.83
－4.05
Deviation
2.67
1.28
1.25
1.04
1.75
2.13
t value
－0.726
－0.298
－0.516
1.705
0.809
1.436
P value
0.474
0.770
0.610
0.109
0.430
0.170
Table 6 Analytical determination of the effects of medication usage and the change of intraocular pressure of the experimental
group
Item
Right eye
Left eye
Effect after stimulation
Instant effect
Effect after 30 min
Effect after 60 min
Instant effect
Effect after 30 min
Effect after 60 min
Medicine-taking
n
30
30
30
17
18
18
r value
－0.132
－0.039
0.056
0.217
0.149
0.539
P value
0.488
0.836
0.767
0.402
0.555
0.021
Notes: if the values were negative, this denotes decrease of intraocular pressure; the treatment was effective. If the values were positive, this
denotes an elevation of intraocular pressure; the treatment was ineffective.
Table 5 Analytical determination of the related analyses of age and the changes of intraocular pressure of the experimental group.
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